1. Home
  2. CNF vs HLN Comparison

CNF vs HLN Comparison

Compare CNF & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNF

CNFinance Holdings Limited each representing twenty (20)

HOLD

Current Price

$6.00

Market Cap

35.7M

Sector

Finance

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.55

Market Cap

41.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNF
HLN
Founded
1999
2022
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Package Goods/Cosmetics
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.7M
41.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CNF
HLN
Price
$6.00
$9.55
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
10.5K
10.0M
Earning Date
08-28-2025
07-31-2025
Dividend Yield
N/A
1.91%
EPS Growth
N/A
41.64
EPS
N/A
0.23
Revenue
$50,241,013.00
$15,096,588,575.00
Revenue This Year
$252.34
$1.51
Revenue Next Year
N/A
$4.67
P/E Ratio
N/A
$20.45
Revenue Growth
N/A
N/A
52 Week Low
$2.36
$8.71
52 Week High
$13.90
$11.42

Technical Indicators

Market Signals
Indicator
CNF
HLN
Relative Strength Index (RSI) 63.24 49.53
Support Level $5.60 $9.30
Resistance Level $6.01 $9.65
Average True Range (ATR) 0.27 0.14
MACD 0.03 -0.03
Stochastic Oscillator 99.17 35.71

Price Performance

Historical Comparison
CNF
HLN

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: